These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Moleculin Biotech (MBRX) has received FDA feedback and guidance on its IND amendment that has allowed a reduction in the size of its Phase 3 pivotal trial protocol evaluating Annamycin in ...

Moleculin Biotech stock surged on high volume after FDA guidance allowed a 10% reduction in its Phase 3 trial for Annamycin. The MIRACLE Phase 3 study's first unblinding at 45 subjects is expected ...

Story Feb. 13 - Moderna: The big biotech is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees. The IT workforce reductions come as ...

JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved… accelant, a leader in sales, marketing, and revenue operations, is thrilled to announc ...

Edesa Biotech, Inc. announced a successful private placement led by Velan Capital, raising approximately $15 million to advance its CXCL10 antibody program through fiscal 2026. The offering ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Today, a new artificial intelligence (AI)-driven biotech company emerges from stealth and it might not be the last time you hear its name. Latent Lab steps into the spotlight with a $40 million series ...

4D Molecular Therapeutics Inc. 3.39% $225.59M ...

Tri Pointe faces challenges from high mortgage rates and housing affordability, despite impressive earnings and revenue ...

Join biotech commentators Daphne Zohar, Josh Schimmer, and Brad Loncar for a weekly discussion of all things biotech. From emerging trends and investment opportunities to the challenges facing the ...

And biotech companies using metabolomics are advancing promising candidates. By profiling metabolites, researchers can identify novel biomarkers for diseases, understand disease mechanisms, and ...